S&P 500

6.050,61

-0,39%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NYSE
Penumbra Inc (PEN)
Penumbra Inc (PEN) Notícias

PEN

Penumbra (PEN)

Penumbra Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NYSE:PEN

1 2 3 4 5 6 7 8 9 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
17/12/2024	21:35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:PEN	Penumbra Inc
02/12/2024	18:05	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:PEN	Penumbra Inc
20/11/2024	18:30	PR Newswire (US)	Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference	NYSE:PEN	Penumbra Inc
12/11/2024	14:53	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NYSE:PEN	Penumbra Inc
05/11/2024	11:00	PR Newswire (US)	New Late Breaking Data Show Patients Treated with Penumbra's Computer Assisted Vacuum Thrombectomy Technology for Pulmonary Embolism Experience Shorter Hospital Stays and Fewer Complications Compared to Other Treatment Options	NYSE:PEN	Penumbra Inc
30/10/2024	17:47	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:PEN	Penumbra Inc
30/10/2024	17:14	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:PEN	Penumbra Inc
30/10/2024	17:05	PR Newswire (US)	Penumbra, Inc. Reports Third Quarter 2024 Financial Results	NYSE:PEN	Penumbra Inc
14/10/2024	10:00	PR Newswire (US)	Penumbra, Inc. Announces Completion of THUNDER IDE Study Enrollment for Acute Ischemic Stroke	NYSE:PEN	Penumbra Inc
02/10/2024	17:30	PR Newswire (US)	Penumbra, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for October 30, 2024	NYSE:PEN	Penumbra Inc
16/09/2024	04:00	PR Newswire (US)	Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash™ 2.0 and Lightning Bolt™ 7 - in Europe	NYSE:PEN	Penumbra Inc
27/08/2024	17:30	PR Newswire (US)	Penumbra, Inc. to Present at the Baird Global Healthcare Conference	NYSE:PEN	Penumbra Inc
21/08/2024	17:30	PR Newswire (US)	Penumbra, Inc. to Present at the Wells Fargo Healthcare Conference	NYSE:PEN	Penumbra Inc
13/08/2024	08:00	PR Newswire (US)	Penumbra, Inc. Announces $200 Million Share Repurchase Authorization	NYSE:PEN	Penumbra Inc
02/08/2024	17:30	PR Newswire (US)	Penumbra, Inc. to Present at the Canaccord Genuity Growth Conference	NYSE:PEN	Penumbra Inc
30/07/2024	17:05	PR Newswire (US)	Penumbra, Inc. Reports Second Quarter 2024 Financial Results	NYSE:PEN	Penumbra Inc
02/07/2024	17:05	PR Newswire (US)	Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024	NYSE:PEN	Penumbra Inc
04/06/2024	17:30	PR Newswire (US)	Penumbra, Inc. to Present at the Truist Securities MedTech Conference	NYSE:PEN	Penumbra Inc
31/05/2024	17:39	Edgar (US Regulatory)	Form SD - Specialized disclosure report	NYSE:PEN	Penumbra Inc
23/05/2024	17:30	PR Newswire (US)	Penumbra, Inc. to Present at the William Blair Growth Stock Conference	NYSE:PEN	Penumbra Inc
07/05/2024	17:05	PR Newswire (US)	Penumbra, Inc. Reports First Quarter 2024 Financial Results	NYSE:PEN	Penumbra Inc
01/05/2024	17:05	PR Newswire (US)	Penumbra, Inc. to Present at the RBC Capital Markets Global Healthcare Conference	NYSE:PEN	Penumbra Inc
23/04/2024	10:00	PR Newswire (US)	Penumbra Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots	NYSE:PEN	Penumbra Inc
09/04/2024	17:05	PR Newswire (US)	Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024	NYSE:PEN	Penumbra Inc
22/02/2024	18:46	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NYSE:PEN	Penumbra Inc
22/02/2024	18:05	PR Newswire (US)	Penumbra, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results	NYSE:PEN	Penumbra Inc
09/02/2024	19:46	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NYSE:PEN	Penumbra Inc
01/02/2024	18:05	PR Newswire (US)	Penumbra, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 22, 2024	NYSE:PEN	Penumbra Inc
18/12/2023	21:50	PR Newswire (US)	Penumbra, Inc. to Present at the J.P. Morgan 42nd Annual Healthcare Conference	NYSE:PEN	Penumbra Inc
28/11/2023	11:00	PR Newswire (US)	First Patient in STORM-PE RCT Enrolled Evaluating Penumbra's Latest Computer Assisted Vacuum Thrombectomy - Lightning Flash™ - for Treatment of Acute Pulmonary Embolism	NYSE:PEN	Penumbra Inc